XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.2
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
6 Months Ended
Jun. 30, 2024
Fair Value Disclosures [Abstract]  
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS
DERIVATIVES AND HEDGING.

Our primary objective in executing and holding derivative contracts is to reduce the volatility of earnings and cash flows associated with risks related to foreign currency exchange rates, interest rates, and equity prices. These derivative contracts reduce, but do not entirely eliminate, the aforementioned risks. Our policy is to use derivative contracts solely for managing risks and not for speculative purposes.

Cash Flow Hedges
For derivative instruments designated as cash flow hedges, changes in the fair value of designated hedging instruments are initially recorded as a component of AOCI and subsequently reclassified to earnings in the period in which the hedged transaction affects earnings and to the same financial statement line item impacted by the hedged transaction. As of June 30, 2024, we expect to reclassify $7 million of pre-tax net deferred gains associated with designated cash flow hedges to earnings in the next 12 months, contemporaneously with the impact on earnings of the related hedged transactions.

The cash flows associated with derivatives designated as cash flow hedges are recorded in All other operating activities in the Condensed Consolidated Statements of Cash Flows.

Net Investment Hedges
We use cross-currency interest rate swaps and foreign currency forward contracts in combination with foreign currency option contracts to hedge the foreign currency risk associated with our net investment in foreign operations. As of June 30, 2024, these contracts were designated as hedges of our net investment in foreign operations, primarily in Euro and Chinese Renminbi currencies.

The cash flows associated with derivatives designated as net investment hedges are recorded in All other investing activities in the Condensed Consolidated Statements of Cash Flows. Cash flows from the periodic interest settlements on the cross-currency swaps are recorded in All other operating activities in the Condensed Consolidated Statements of Cash Flows.
Fair Value Hedges
We use interest rate swaps to hedge the interest rate risk on our fixed rate borrowings. These derivatives are designated as fair value hedges to hedge the changes in fair value due to benchmark interest rate risk of specific designated cash flows of our senior unsecured notes.
We record the changes in fair value on these swap contracts in Interest and other financial charges – net in our Condensed Consolidated Statements of Income, the same line item where the offsetting change in the fair value of the designated cash flows of the senior unsecured note is recorded as a basis adjustment.

Cash flows for the periodic interest settlements on the interest rate swaps are recorded in All other operating activities in the Condensed Consolidated Statements of Cash Flows.
Derivatives Not Designated as Hedging Instruments
We also execute derivative instruments, such as foreign currency forward contracts and equity-linked total return swaps, which are not designated as qualifying hedges. These derivatives serve as economic hedges of the foreign currency rate risk and equity price risk. We also identify and record foreign currency-related features in our purchase or sales contracts where the currency is not the local or functional currency of any substantive party to the contract and record them as embedded derivatives.

The changes in fair value of derivatives not designated in qualifying hedge transactions are recorded in Cost of products, Cost of services, Selling, general, and administrative (“SG&A”), and Other (income) expense – net in the Condensed Consolidated Statements of Income based on the nature of the underlying hedged transaction. Changes in fair value of embedded derivatives are recognized in Other (income) expense – net in the Condensed Consolidated Statements of Income.

The cash flows associated with derivatives not designated but used as economic hedges are recorded, based on the nature of the underlying hedged transaction, in All other operating activities and All other investing activities in the Condensed Consolidated Statements of Cash Flows. The cash flows related to embedded derivatives are included in All other operating activities in the Condensed Consolidated Statements of Cash Flows.

The following table presents the gross fair values of our outstanding derivative instruments.

Fair Value of DerivativesJune 30, 2024December 31, 2023
Gross NotionalFair Value – AssetsFair Value – LiabilitiesGross NotionalFair Value – AssetsFair Value – Liabilities
Foreign currency forward contracts
$1,411 $21 $13 $1,356 $$30 
Derivatives accounted for as cash flow hedges1,411 21 13 1,356 8 30 
Cross-currency swaps(1)
2,149 — 148 2,209 — 204 
Foreign currency forward and options contracts
1,859 17 12 991 11 
Derivatives accounted for as net investment hedges4,008 17 160 3,200 9 215 
Interest rate swaps(1)
1,700 — 27 1,000 35 10 
Derivatives accounted for as fair value hedges
1,700  27 1,000 35 10 
Foreign currency forward contracts
4,108 3,597 19 12 
Other derivatives(1)(2)
409 25 438 57 
Derivatives not designated as hedging instruments
4,517 34 9 4,035 76 14 
Total derivatives$11,636 $72 $209 $9,591 $128 $269 
(1) Accrued interest was immaterial for the periods presented and is excluded from fair value. These amounts are recognized within All other current assets and All other current liabilities in the Condensed Consolidated Statements of Financial Position.
(2) Other derivatives are comprised of embedded derivatives and derivatives related to equity contracts. As of December 31, 2023, Other derivatives also included commodity contracts.

The following table presents amounts recorded in Long-term borrowings in the Condensed Consolidated Statements of Financial Position related to cumulative basis adjustment for fair value hedges.

June 30, 2024December 31, 2023
Carrying amountCumulative basis adjustment included in the carrying amount
Carrying amount
Cumulative basis adjustment included in the carrying amount
Long-term borrowings designated in fair value hedges
$1,669 $(27)$1,023 $25 

Under the master arrangements with the respective counterparties to our derivative contracts, in certain circumstances and subject to applicable requirements, we are allowed to net settle transactions with a single net amount payable by one party to the other. However, we have elected to present the derivative assets and derivative liabilities on a gross basis on our Condensed Consolidated Statements of Financial Position and in the table above.

As of June 30, 2024 and December 31, 2023, the potential effect of rights of offset associated with the derivative contracts would be an offset to both assets and liabilities by $41 million, respectively.

The table below presents the pre-tax gains (losses) recognized in OCI associated with the Company’s cash flow and net investment hedges.
Pre-tax Gains (Losses) Recognized in OCI Related to Cash Flow and Net Investment Hedges
For the three months ended June 30
For the six months ended June 30
2024202320242023
Cash flow hedges$11 $$31 $(10)
Net investment hedges(1)
27 (36)59 (71)
(1) Amounts recognized in OCI for excluded components for the periods presented were immaterial.

The tables below present the gains (losses) on our derivative financial instruments and hedging activity in the Condensed Consolidated Statements of Income.

Derivative Financial Instruments and Hedging Activity
For the three months ended June 30, 2024
Cost of productsCost of services
SG&A
Interest and other financial charges net
Other(3)
Foreign currency forward contracts
$$— $— $— $— 
Effects of cash flow hedges1     
Cross-currency swaps— — — — 
Foreign currency forward and options contracts
— — — — 
Effects of net investment hedges(1)
   11  
Interest rate swaps(4)
— — — (21)— 
Debt basis adjustment on Long-term borrowings
— — — 14 — 
Effects of fair value hedges
   (7) 
Foreign currency forward contracts
— — — 
Other derivatives(2)
— — — 
Effects of derivatives not designated as hedging instruments
5 1 1  3 

For the three months ended June 30, 2023
Cost of productsCost of services
SG&A
Interest and other financial charges net
Other(3)
Foreign currency forward contracts$(5)$(1)$— $— $— 
Effects of cash flow hedges(5)(1)   
Cross-currency swaps— — — — 
Foreign currency forward and option contracts    — 
Effects of net investment hedges(1)
   9  
Interest rate swaps
— — — — — 
Debt basis adjustment on Long-term borrowings— — — — — 
Effects of fair value hedges     
Foreign currency forward contracts— — 
Other derivatives(2)
— — 18 — — 
Effects of derivatives not designated as hedging instruments
3 1 18  4 
For the six months ended June 30, 2024
Cost of productsCost of services
SG&A
Interest and other financial charges net
Other(3)
Foreign currency forward contracts
$— $— $— $— $— 
Effects of cash flow hedges     
Cross-currency swaps— — — 17 — 
Foreign currency forward and options contracts
— — — — 
Effects of net investment hedges(1)
   21  
Interest rate swaps(4)
— — — (66)— 
Debt basis adjustment on Long-term borrowings
— — — 52 — 
Effects of fair value hedges
   (13) 
Foreign currency forward contracts
(7)(2)— — — 
Other derivatives(2)
— — — 23 
Effects of derivatives not designated as hedging instruments
(7)(2)5  23 

For the six months ended June 30, 2023
Cost of productsCost of services
SG&A
Interest and other financial charges net
Other(3)
Foreign currency forward contracts$22 $$— $— $— 
Effects of cash flow hedges22 5    
Cross-currency swaps— — — 17 — 
Foreign currency forward and option contracts
    — 
Effects of net investment hedges(1)
   17  
Interest rate swaps
— — — — — 
Debt basis adjustment on Long-term borrowings
— — — — — 
Effects of fair value hedges     
Foreign currency forward contracts10 — — 
Other derivatives(2)
— — 33 — — 
Effects of derivatives not designated as hedging instruments
10 3 33  5 
(1) Changes in fair value related to components other than the spot rate are excluded from effectiveness testing for the three and six months ended June 30, 2024 and 2023.
(2) Other derivatives are primarily comprised of embedded derivatives and derivatives related to equity contracts.
(3) Amounts are inclusive of gains (losses) in Other (income) expense – net in the Condensed Consolidated Statements of Income.
(4) Amount includes $(7) million and $(13) million of interest expense on interest rate derivatives for the three and six months ended June 30, 2024, respectively.

FAIR VALUE MEASUREMENTS.

The following table represents assets and liabilities that are recorded and measured at fair value on a recurring basis.

Fair Value of Assets and Liabilities Measured on a Recurring Basis
As of June 30, 2024
As of December 31, 2023
Level 1Level 2Level 3TotalLevel 1Level 2Level 3Total
Assets:
Money market funds
$— $215 $— $215 $— $200 $— $200 
Investment securities26 — — 26 31 — — 31 
Derivatives
— 72 — 72 — 128 — 128 
Liabilities:
Deferred compensation
237 — 243 264 — 269 
Derivatives
— 209 — 209 — 269 — 269 
Contingent consideration— — 42 42 — — 44 44 
Cash equivalents
As of June 30, 2024 and December 31, 2023, Cash, cash equivalents and restricted cash of $2,015 million and $2,504 million, respectively, included money market funds of $215 million and $200 million, and other cash equivalents of $695 million and $1,023 million, respectively. The carrying values of the other cash equivalents approximate fair value due to their short maturities and are valued using Level 1 or Level 2 inputs.

Deferred compensation
The deferred compensation liabilities as of June 30, 2024 and December 31, 2023 are comprised of market-based obligations indexed to the S&P 500 index fund and GE HealthCare stock in Level 1, and mutual funds in Level 2.

Derivatives
Derivatives are measured at fair value using a discounted cash flow method or option models using interest rates, foreign exchange spot and forward rates and yield curves observable at commonly quoted intervals, implied volatilities, and credit spreads as key inputs. Unobservable inputs relate to our own credit risk which is not significant to the overall measurement of fair value.

Contingent consideration
The contingent consideration liabilities as of June 30, 2024 and December 31, 2023 were recorded in connection with business acquisitions. The contingent consideration is recorded at fair value based on estimates of future cash flows associated with the acquired businesses. To the extent that the valuation of these liabilities is based on inputs that are less observable or not observable in the market, the determination of fair value requires more judgment. Accordingly, the fair value of contingent consideration is classified within Level 3 of the fair value hierarchy.

Non-recurring fair value measurements
Changes in fair value measurements of assets and liabilities measured at fair value on a non-recurring basis, such as equity method investments, equity investments without readily determinable fair value, financing receivables, and long-lived assets, were not material for the six months ended June 30, 2024 and 2023.

Fair value of other financial instruments
The estimated fair value of borrowings as of June 30, 2024 and December 31, 2023 was $9,609 million and $9,959 million, respectively, compared to a carrying value (which includes a reduction for unamortized debt issuance costs and discounts and cumulative basis adjustment) of $9,240 million and $9,442 million, respectively. The fair value of our borrowings includes accrued interest and is determined based on observable and quoted prices and spreads of comparable debt and benchmark securities and is considered Level 2 in the fair value hierarchy. See Note 8, “Borrowings” for further information.